Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (6): 103-110.doi: 10.6040/j.issn.1671-7554.0.2020.1656
Previous Articles Next Articles
XU Bing1, LI Yong2, LIU Ming1, LIU Yonghui1
CLC Number:
[1] Zhu Y, Freedland SJ, Ye D. Prostate cancer and prostatic diseases best of Asia, 2019: challenges and opportunities [J]. Prostate Cancer Prostatic Dis, 2020, 23(2): 197-198. [2] Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells [J]. Cancer Cell, 2012, 22(3): 373- 388. [3] 李宁宁, 郭振英. PRRX1 在 EMT 及维持肿瘤干性中的研究进展[J]. 临床与实验病理学杂志, 2018, 34(4): 83-85. LI Ningning, GUO Zhenying. Research progress of PRRX1 in EMT and maintenance of tumor dryness [J]. Chinese Journal of Clinical and Experimental Pathology, 2018, 34(4): 83-85. [4] Dong J, Lv Z, Chen Q, et al. PRRX1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells [J]. Int J Clin Exp Pathol, 2018, 11(5): 2629-2635. [5] Wang S, Ping M, Song B, et al. Exosomal circ PRRX1 enhances doxorubicin resistance in gastric cancer by regulating miR-3064-5p/PTPN14 signaling [J]. Yonsei Med J, 2020, 61(9): 750-761. [6] 朱小长, 陶连元, 杜瀛瀛, 等. mTOR抑制剂通过mTOR通路介导胰腺癌顺铂耐药的机制研究[J]. 安徽医科大学学报, 2019, 54(8): 1205-1210. ZHU Xiaozhang, TAO Lianyuan, DU Yingying, et al. Mechanism of mTOR inhibitors in cisplatin resistance in pancreatic cancer by mediating the mTOR pathway [J]. Acta Universitatis Medicinalis Anhui, 2019, 54(8): 1205-1210. [7] Gremke N, Polo P, Dort A, et al. mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability [J]. Nat Commun, 2020, 11(1): 4684. [8] 马琪, 李永红, 杨斌, 等. 前列腺癌化疗安全共识[J]. 现代泌尿外科杂志, 2018, 23(2): 85-92. MA Qi, LI Yonghong, YANG Bin, et al. Consensus on the safety of chemotherapy for prostate cancer [J]. Journal of Modern Urology, 2018, 23(2): 85-92. [9] 林建中, 朱佳庚, 吴宏飞, 等. AXL表达在前列腺癌细胞多西他赛耐药中的作用研究[J]. 中华男科学杂志, 2017, 23(4): 302-308. LIN Jianzhong, ZHU Jiageng, WU Hongfei, et al. Expression of AXL enhances docetaxel-resistance of prostate cancer cells [J]. National Journal of Andrology, 2017, 23(4): 302-308. [10] Li Y, Yang R, Henzler CM, et al. Diverse AR gene rearrangements mediate resistance to androgen receptor inhibitors in metastatic prostate cancer [J]. Clin Cancer Res, 2020, 26(8): 1965-1976. [11] 王仕钦, 江春, 黄卫, 等. 普萘洛尔抑制前列腺癌发展的分子机制[J]. 医药导报, 2020, 39(6): 763-769. WANG Shiqin, JIANG Chun, HUANG Wei, et al. Molecular mechanisms of propranolol inhibits the progression of prostate cancer [J]. Herald of Medicine, 2020, 39(6): 763-769. [12] Spreafico A, Chi KN, Sridhar SS, et al. A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients [J]. Invest New Drugs, 2014, 32(5): 1005-1016. [13] 范钰, 蒋孟林, 满昌峰, 等. 配对相关同源框-1基因过表达对人胰腺癌细胞侵袭及上皮-间充质转化的影响[J]. 中华实验外科杂志, 2016, 33(7): 1789-1791. FAN Yu, JIANG Menglin, MAN Changfeng, et al. Effects of overexpression of paired-related homeobox 1 gene on invasion and epithelial mesenchymal transition of human pancreatic cancer cells [J]. Chinese Journal of Experimental Surgery, 2016, 33(7): 1789-1791. [14] Tang Y, Lu Y, Chen Y, et al. Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1 [J]. J Exp Clin Cancer Res, 2019, 38(1): 473. [15] Hirata H, Sugimachi K, Takahashi Y, et al. Downregulation of PRRX1 confers cancer stem cell-like properties and predicts poor prognosis in hepatocellular carcinoma [J]. Ann Surg Oncol, 2015, 22(Suppl 3): 1402-1409. [16] Nagai MH, Xavier VPS, Gutiyama LM, et al. Depletion of Ric-8B leads to reduced mTORC2 activity [J]. PLoS Genet, 2020, 16(5): 1008255. [17] Murugan AK. mTOR: role in cancer, metastasis and drug resistance [J]. Semin Cancer Biol, 2019, 59: 92-111. doi: 10.1007/978-3-030-20301-6_15. [18] Cristofani R, Montagnani MM, Cicardi ME, et al. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells [J]. Cell Death Dis, 2018, 9(9):889. [19] Smith AG, Macleod KF. Autophagy, cancer stem cells and drug resistance [J]. J Pathol, 2019, 247(5): 708-718. |
[1] | GE Li-Juan, JIN Rui-Feng, WANG Ji-Wen, HU Xin-Sheng, LIKun. Association between the C1236T polymorphism in multi-drug resistance gene 1 and response to antiepileptic drug treatment in epileptic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 99-102. |
[2] | SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50. |
[3] | XU Zhen, DIAO Tongxiang, ZANG Zhenjie, SHAO Dingchang, ZHANG Qi, SUN Dingqi, FU Qiang. Value of isoform[-2]proprostate-specific antigen and its derivatives in the diagnosis of prostate cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 51-56. |
[4] | LI Yan, LIU Jing, LI Juan, YANG Qiuhong. Clinical characteristics and placental pathology of bloodstream infection in 50 pregnant women [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 48-54. |
[5] | Jianhua JU,Zhenye YANG,Qinglian LI,Ya'nan HAN,Yanqing LI,Yijun QIAO,Hu YANG,Huaran ZHANG. Advances on drugs derived from microbial sources and future perspectives [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 43-50,63. |
[6] | Chunfang HA,Ruyue LI. Research progress of drug resistance in ovarian cancer and targeted therapy strategy [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 117-123. |
[7] | Benkang SHI,Shouzhen CHEN,Sifeng QU,Yong WANG,Lei LIU. Research progress and clinical characteristics of clinical rapidly progressing prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 110-116. |
[8] | SUN Dingqi, FU Qiang, ZHANG Hui, LIU Shuai, DIAO Tongxiang, CAO Qingwei, ZHANG Keqin. Clinical value of targeted multiparameter MRI and transrectal ultrasonography fusion prostate biopsy for the detection of PI-RADS≥3 prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 108-113. |
[9] | ZHANG Xiaohong, ZHOU Yun, DU Qiuying, REN Huixin, WANG Chaoqun. Atg7-siRNA interferes with radiosensitivity of esophageal cancer ECA109 cells by regulating arginine circulation [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 28-34. |
[10] | FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24-31. |
[11] | SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1-6. |
[12] | SUN Wenkai, SUN Hui, WU Xinfang, GAO Wei, MENG Zhaotun, LI Qin. Expressions and clinical significance of Beclin-1, P62 and Ki67 in different parts of nasal polyps [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 76-82. |
[13] | SUN Panpan, ZHAO Xu, LIN Xiaowen, FU Zhijian. Effects of medical ozone on the expression of PPARγ and autophagy in chondrocytes of osteoarthritis in rats [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 14-21. |
[14] | FU Zhenmei, MA Mingze. Expression of P-glycoprotein in the colonic mucosa of ulcerative colitis patients and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 54-59. |
[15] | ZHANG Ning, YANG Yan, LI Rui, YIN Yunhong, LI Hao, QU Yiqing. Analysis of risk factors and drug resistance of Acinetobacter baumannii in patients with chronic obstructive pulmonary disease [J]. Journal of Shandong University (Health Sciences), 2019, 57(9): 88-96. |
|